# Validation and longitudinal trajectory analysis of an AI-based ECG model for aortic stenosis: from community screening to pre-TAVR risk stratification

**Authors:** Matthew W Segar, Kaleb D Lambeth, Alexander Postalian, Stephanie Coulter, Jasen Gilge, Naveed Razvi, Mohammad Saeed, Robert D Paisley, Ambarish Pandey, Mehdi Razavi

PMC · DOI: 10.1093/ehjdh/ztag018 · European Heart Journal. Digital Health · 2026-02-03

## TL;DR

An AI-based ECG model can detect early signs of aortic stenosis and predict future risk, even years before treatment.

## Contribution

The study validates an AI model for aortic stenosis detection and shows its ability to predict disease progression and mortality risk.

## Key findings

- The AK-AVS model achieved 79% AUROC in detecting moderate/severe aortic stenosis in community screening.
- AI-ECG trajectory patterns predicted mortality risk up to 4.5 years before TAVR, outperforming traditional risk scores.
- False-positive predictions identified individuals with higher future risk of AS hospitalization and heart failure.

## Abstract

Early aortic stenosis (AS) detection remains challenging, with many patients presenting late when left ventricular dysfunction may be irreversible. We evaluated whether longitudinal AI-enhanced ECG patterns can predict outcomes years before intervention and assessed the community screening potential of the AK-AVS model.

We conducted two complementary analyses: (1) community validation of the AK-AVS model in 3632 cardiovascular disease-free ARIC participants, and (2) longitudinal trajectory analysis of 7860 ECGs from 2040 TAVR recipients collected up to 10 years pre-procedure. Unsupervised clustering identified distinct AK-AVS trajectories, with mortality associations assessed using Cox regression and net reclassification improvement. In community screening (n = 16 moderate/severe AS), AK-AVS achieved an AUROC of 0.79, sensitivity 75%, and specificity 75% for moderate/severe AS. At hypothetical screening prevalences of 1–5%, positive predictive values improved to 3.1–14.3%. False-positive predictions identified individuals at 4-fold increased risk for future AS hospitalisation (HR 4.05, P < 0.001) and 52% increased risk for heart failure (HR 1.52, P = 0.02). In the TAVR cohort, trajectory analysis revealed three distinct patterns: Stable Low (19.3%), Accelerated Progression (23.6%), and Persistently High (57.1%). Elevated trajectory groups were older (78.4 and 77.8 vs. 72.6 years, P < 0.001) with higher pacemaker rates (16.4% and 17.3% vs. 10.7%, P = 0.008), despite similar hemodynamic severity. Both elevated patterns independently predicted mortality (Accelerated: HR 1.40, P = 0.03; Persistently High: HR 1.48, P = 0.005) and significantly improved risk reclassification beyond traditional risk scores (NRI 0.069–0.074).

Longitudinal AI-ECG trajectory patterns detect disease progression up to 4.5 years before TAVR and enhance mortality prediction beyond traditional risk scores. Community validation shows potential screening utility with ‘false-positives’ identifying future risk.

Graphical Abstract

## Linked entities

- **Diseases:** aortic stenosis (MONDO:0042981), heart failure (MONDO:0005252)

## Full-text entities

- **Genes:** NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}, GDF15 (growth differentiation factor 15) [NCBI Gene 9518] {aka GDF-15, HG, MIC-1, MIC1, NAG-1, PDF}
- **Diseases:** congenital aortic valve disease (MESH:D000082862), aortic valve calcification (MESH:C562942), stenosis (MESH:D003251), Cardiomyopathy (MESH:D009202), COPD (MESH:D029424), AK-AVS (MESH:D001024), left ventricular dysfunction (MESH:D018487), AI (MESH:C538142), chronic kidney disease (MESH:D051436), ventricular dysfunction (MESH:D018754), valvular disease (MESH:D006349), diabetes (MESH:D003920), impairment of (MESH:D060825), fibrosis (MESH:D005355), coronary artery disease (MESH:D003324), heart disease (MESH:D006331), cardiac remodelling (MESH:D020257), heart failure (MESH:D006333), congenital heart disease (MESH:D006330), STS (MESH:D016114), myocardial infarction (MESH:D009203), cardiovascular disease (MESH:D002318), CKD (MESH:D012080), ARIC (MESH:D050197), left ventricular hypertrophy (MESH:D017379), deaths (MESH:D003643), hemodynamic abnormalities (MESH:D000014)
- **Chemicals:** calcium (MESH:D002118)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12912914/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12912914/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12912914/full.md

---
Source: https://tomesphere.com/paper/PMC12912914